跳至主要内容
临床试验/PACTR202003714748946
PACTR202003714748946已完成未知

The Efficacy of topical Capsaicin in the management of painful diabetic peripheral neuropathy: A unicenter double-blind, randomized clinical trial

未提供0 个研究点目标入组 22 人开始时间: 2020年3月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Year(s) 至 64 Year(s)(—)
性别
All

入选标准

  • All were patients with type 2 diabetes who had daily pain or painful paresthesias in a neuropathic or radiculopathic distribution, intensity between 4 and 7 on a visual analogic scale, interfering with daily activities, work or sleep for at least 3 months duration.

排除标准

  • History of allergies to any capsaicin product
  • Diabetic patients with other diagnosed etiology responsible for peripheral neuropathy such as hepatitis, AIDS, Nutritional deficiencies (folate, vitamin B12)
  • Presence of open skin lesions at the site of application of the study medication
  • Signs of infection on limbs or amputations
  • Pregnant or lactating females
  • Subjects with other topical medication at site of application of study cream.
  • All eligible patients who did not give their signed informed consent to participate

研究者

发起方
未提供

相似试验